145 related articles for article (PubMed ID: 20812032)
1. Synthesis and evaluation of 99mTc-labelled monoclonal antibody 1D09C3 for molecular imaging of major histocompatibility complex class II protein expression.
Malviya G; de Vries EF; Dierckx RA; Signore A
Mol Imaging Biol; 2011 Oct; 13(5):930-9. PubMed ID: 20812032
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
[TBL] [Abstract][Full Text] [Related]
3. Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis.
Yamaguchi M; McSweeney PA; Kimball L; Gersuk G; Hong DS; Kwok W; Storb R; Beckham C; Deeg HJ
Transplantation; 1999 Oct; 68(8):1161-71. PubMed ID: 10551646
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
Stalteri MA; Mather SJ
Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
[TBL] [Abstract][Full Text] [Related]
6. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.
Gratz S; Behr T; Herrmann A; Dresing K; Tarditi L; Franceschini R; Rhodes B; Stürmer KM; Becker W
Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168
[TBL] [Abstract][Full Text] [Related]
7. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
[TBL] [Abstract][Full Text] [Related]
9. 1D09C3, an mAb specific for MHC-II.
Zola H; Beare A
Curr Opin Mol Ther; 2008 Feb; 10(1):68-74. PubMed ID: 18228184
[TBL] [Abstract][Full Text] [Related]
10. Radioimmuno targetting (99m)technetium labeled anti-epidermal growth factor receptor monoclonal antibodies in experimental tumor models.
Meenakshi A; Ganesh V; Suresh Kumar R; Siva Kumar N
Q J Nucl Med; 2003 Jun; 47(2):139-44. PubMed ID: 12865874
[TBL] [Abstract][Full Text] [Related]
11. (99m)Tc-labeled rituximab for imaging B lymphocyte infiltration in inflammatory autoimmune disease patients.
Malviya G; Anzola KL; Podestà E; Laganà B; Del Mastro C; Dierckx RA; Scopinaro F; Signore A
Mol Imaging Biol; 2012 Oct; 14(5):637-46. PubMed ID: 22127469
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab.
Stein R; Qu Z; Chen S; Solis D; Hansen HJ; Goldenberg DM
Blood; 2006 Oct; 108(8):2736-44. PubMed ID: 16778139
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
Goel A; Baranowska-Kortylewicz J; Hinrichs SH; Wisecarver J; Pavlinkova G; Augustine S; Colcher D; Booth BJ; Batra SK
J Nucl Med; 2001 Oct; 42(10):1519-27. PubMed ID: 11585867
[TBL] [Abstract][Full Text] [Related]
14. Molecular specificity of a monoclonal anti-Ik alloantibody identifying a highly conserved determinant on mouse I-A, I-E and human DR antigens.
Pierres M; Lafuse WP; Dosseto M; Devaux C; Birnbaum DZ; David CS
Tissue Antigens; 1982 Sep; 20(3):208-20. PubMed ID: 6182640
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Imaging of Natural Killer Cell Trafficking in Tumors.
Galli F; Rapisarda AS; Stabile H; Malviya G; Manni I; Bonanno E; Piaggio G; Gismondi A; Santoni A; Signore A
J Nucl Med; 2015 Oct; 56(10):1575-80. PubMed ID: 26272812
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m direct radiolabeling of monoclonal antibody ior egf/r3.
Morales AA; Crespo FZ; Gandolff GN; Iznaga Escobar N; Pérez NP; Hernández JC
Nucl Med Biol; 1998 Jan; 25(1):25-30. PubMed ID: 9466358
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3.
Carlo-Stella C; Guidetti A; Di Nicola M; Lavazza C; Cleris L; Sia D; Longoni P; Milanesi M; Magni M; Nagy Z; Corradini P; Carbone A; Formelli F; Gianni AM
Cancer Res; 2007 Apr; 67(7):3269-75. PubMed ID: 17409435
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and preparation of technetium-99m-labeled D-D₃ monoclonal antibody against pro-gastrin-releasing peptide (₃₁₋₉₈) in mice.
Hao LJ; Hong ZH; Shi YZ; Liu ZL; Zhou XL
Chin Med J (Engl); 2013 Apr; 126(7):1333-6. PubMed ID: 23557567
[TBL] [Abstract][Full Text] [Related]
19. Anomalies in reduction-mediated technetium-99m labelling of monoclonal antibodies.
Pimm MV; Rajput RS; Frier M; Gribben SJ
Eur J Nucl Med; 1991; 18(12):973-6. PubMed ID: 1778209
[TBL] [Abstract][Full Text] [Related]
20. Syngeneic anti-idiotypes against monoclonal anti-HLA-DR antibodies: characterization of recurrent idiotopes.
Piatier-Tonneau D; Boyer B; Debre P; Charron DJ
J Immunol; 1983 Sep; 131(3):1339-43. PubMed ID: 6193186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
